Europe Molecular Biology Enzymes, Reagents And Kits Market Size & Outlook
Related Markets
Europe molecular biology enzymes, reagents and kits market highlights
- The Europe molecular biology enzymes, reagents and kits market generated a revenue of USD 3,911.3 million in 2024.
- The market is expected to grow at a CAGR of 9.1% from 2025 to 2033.
- In terms of segment, kits & reagents was the largest revenue generating type in 2024.
- Kits & Reagents is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2033.
Europe data book summary
| Market revenue in 2024 | USD 3,911.3 million |
| Market revenue in 2033 | USD 8,039.5 million |
| Growth rate | 9.1% (CAGR from 2025 to 2033) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Enzymes |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.3% of the global molecular biology enzymes, reagents and kits market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,248.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Molecular Biology Enzymes, Reagents And Kits Market Scope
Molecular Biology Enzymes, Reagents And Kits Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | http://www.promega.com/es |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| LGC Group | View profile | 1001-5000 | Teddington, Gloucestershire, United Kingdom, Europe | http://www.lgcgroup.com/ |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Europe molecular biology enzymes, reagents and kits market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 61.68% in 2024. Horizon Databook has segmented the Europe molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2021 to 2033.
Europe ranked second after North America in molecular biology enzymes, kits, and reagents market with 27.35% revenue share in 2019. This can be attributed to increasing research funding, growing biotechnology industry, and rising investments in genomic sequencing in countries such as the UK and Germany.
Furthermore, European Molecular Biology Laboratory is a flagship laboratory in Europe, which is associated with more than 80 research groups working in molecular biology arena. Moreover, various conferences, such as the International Molecular Diagnostics Europe organized in May 2019, are expected to increase the adoption of molecular diagnostics in European region.
In addition, the European Commission is providing funding for developing various diagnostic tests and projects related to disease modeling. For instance, in June 2019, European Fund for Strategic Investments (EFSI) provided a 4-year loan to Mobidiag, Inc. to develop and commercialize diagnostic platforms for small laboratories.
Reasons to subscribe to Europe molecular biology enzymes, reagents and kits market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe molecular biology enzymes, reagents and kits market databook
-
Our clientele includes a mix of molecular biology enzymes, reagents and kits market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This continent databook contains high-level insights into Europe molecular biology enzymes, reagents and kits market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe molecular biology enzymes, reagents and kits market size, by country, 2021-2033 (US$M)
Europe Molecular Biology Enzymes, Reagents And Kits Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
